These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 10821793

  • 1. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M.
    Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 and adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Amano H, Haysahi I, Yoshida S, Yoshimura H, Majima M.
    Hum Cell; 2002 Mar; 15(1):13-24. PubMed ID: 12126060
    [Abstract] [Full Text] [Related]

  • 3. [Endogenous prostaglandins and angiogenesis].
    Majima M, Amano H, Hayashi I.
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):283-92. PubMed ID: 11338378
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK, Hirasawa N, Niki H, Ohuchi K.
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [Abstract] [Full Text] [Related]

  • 5. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
    Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
    Cheng T, Cao W, Wen R, Steinberg RH, LaVail MM.
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
    [Abstract] [Full Text] [Related]

  • 7. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants.
    Majima M, Isono M, Ikeda Y, Hayashi I, Hatanaka K, Harada Y, Katsumata O, Yamashina S, Katori M, Yamamoto S.
    Jpn J Pharmacol; 1997 Oct; 75(2):105-14. PubMed ID: 9414024
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
    Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC.
    Clin Exp Metastasis; 1999 Oct; 17(8):687-94. PubMed ID: 10919714
    [Abstract] [Full Text] [Related]

  • 9. Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor in primary cultured rat astrocytes.
    Liu X, Zheng SX, Zhou LJ, Zhu XZ.
    Acta Pharmacol Sin; 2000 Jan; 21(1):19-22. PubMed ID: 11263242
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M.
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [Abstract] [Full Text] [Related]

  • 11. Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas.
    Muramatsu M, Yamada M, Takai S, Miyazaki M.
    Br J Pharmacol; 2002 Oct; 137(4):554-60. PubMed ID: 12359638
    [Abstract] [Full Text] [Related]

  • 12. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N, Ehrlich K, Gretzer B, Schuligoi R, Respondek M, Peskar BM.
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 14. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T, Tanji N, Sato K, Fujita H, Nishio S, Sakanaka M, Yokoyama M.
    Anticancer Res; 2001 Apr; 21(1A):77-88. PubMed ID: 11299793
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 16. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J, Yan L, Shing Y, Moses MA.
    Cancer Res; 2001 Aug 01; 61(15):5731-5. PubMed ID: 11479208
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 01; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 18. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
    Edelman JL, Castro MR, Wen Y.
    Invest Ophthalmol Vis Sci; 1999 May 01; 40(6):1112-23. PubMed ID: 10235544
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
    Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM.
    Cancer Res; 2002 Jan 15; 62(2):506-11. PubMed ID: 11809702
    [Abstract] [Full Text] [Related]

  • 20. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M.
    Anticancer Res; 2003 Jan 15; 23(1A):245-9. PubMed ID: 12680220
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.